FDA Approval of Flibanserin--Treating Hypoactive Sexual Desire Disorder

N Engl J Med. 2016 Jan 14;374(2):101-4. doi: 10.1056/NEJMp1513686. Epub 2015 Dec 9.

Authors

Hylton V Joffe¹, Christina Chang, Catherine Sewell, Olivia Easley, Christine Nguyen, Somya Dunn, Kimberly Lehrfeld, LaiMing Lee, Myong-Jin Kim, Ashley F Slagle, Julie Beitz

Affiliation

¹ From the Food and Drug Administration, Silver Spring, MD.

PMID: 26649985
DOI: 10.1056/NEJMp1513686

No abstract available

MeSH terms

Advisory Committees
Benzimidazoles / adverse effects
Benzimidazoles / therapeutic use*
Drug Approval*
Drug Interactions
Female
Humans
Premenopause
Serotonin Agents / adverse effects
Serotonin Agents / therapeutic use*
Sexual Dysfunctions, Psychological / drug therapy*
United States
United States Food and Drug Administration*

Substances

Benzimidazoles
Serotonin Agents
flibanserin